Document is current
Any future updates will be listed below
-
Authors
Hanada, Shigeo
Wajima, Takeaki
Takata, Misako
Morozumi, Miyuki
Sato, Yukio
Sasaki, Junichi
Iwata, Satoshi
Ubukata, Kimiko
-
Funding
Funding for this research was provided by:
Japanese Ministry of Health, Labour and Welfare (H22-013)
- License Information
-
More Information
Article History
Received: 10 February 2025
Accepted: 26 March 2025
First Online: 7 April 2025
Declarations
:
: This study was conducted in accordance with the Declaration of Helsinki and Guidelines for Epidemiologic Studies issued by the Japanese Ministry of Health, Labor, and Welfare. The study protocol was approved by the Institutional Review Board of the Keio University School of Medicine Ethics Committee (approval number: 20130455).
: The need for written informed consent was waived owing to the use of anonymized stored samples and data. Patient medical records in the database were obtained anonymously using a survey form completed by the attending physicians.
: Not applicable.
: The following authors received financial support within the last 3 years: K. U. from Pfizer Japan Inc., HORIBA, Ltd., and Abbott Diagnostics Medical Co., Ltd., J. S. from Roche Diagnostics K.K., Sysmex Corporation, Asahi Kasei Pharma Corporation, Shionogi & Co., Ltd., and Pfizer Japan Inc. All other authors declare that they have no conflicts of interest.
